5 Most Valuable Biotech Companies in the World

4. Eli Lilly and Company (NYSE: LLY)

Market Cap: $233.244 billion
Number of Hedge Fund Holders: 55

Eli Lilly and Company (NYSE: LLY) is a pharmaceutical giant that is based in Indianapolis, Indiana. It was founded in 1876 and has since established itself as one of the most valuable biotech companies in the world with a market cap of $233.244 billion. It was the first company that engaged in mass production of the polio vaccine and human insulin by using recombinant DNA. Eli Lilly and Company (NYSE: LLY) has also acquired Protomer Technologies to advance its biotechnology treatments for diabetes. The company’s products are sold in over 125 countries worldwide. It has also acquired another biotech firm that specializes in gene therapy. Overall, 30% of Eli Lilly and Company’s (NYSE: LLY) drug portfolio consists of biotech medicines making it one of the most valuable biotech companies in the world.

Like Pfizer Inc. (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), Novo Nordisk A/S (NYSE: NVO), Moderna, Inc. (NASDAQ: MRNA), and AstraZeneca PLC (NASDAQ: AZN), Eli Lilly and Company (NYSE: LLY) is one of the most valuable biotech companies in the world.